<DOC>
	<DOCNO>NCT00002245</DOCNO>
	<brief_summary>The purpose study evaluate effect 3-drug anti-HIV regimen , amprenavir ( APV ) plus abacavir ( ABC ) plus lamivudine ( 3TC ) , way carbohydrate ( sugar ) fat metabolize ( process body ) HIV-infected patient receive little previous anti-HIV drug therapy .</brief_summary>
	<brief_title>A Study Effects Amprenavir , Protease Inhibitor , Carbohydrate Fat Metabolism HIV-Infected Patients</brief_title>
	<detailed_description>This single-site study use open-label , single-arm design evaluate effect APV , protease inhibitor ( PI ) , plus concurrent nucleoside reverse transcriptase inhibitor ( NRTIs ) ABC 3TC carbohydrate lipid metabolism non-diabetic , HIV-1 infect patient initiate antiretroviral therapy . Treatment duration 24 week , patient serve control . The combination therapy evaluate safety , tolerability , efficacy , effect body composition . The proportion patient attain plasma HIV RNA low limit quantitation Roche Amplicor ( less 400 copies/ml ) Ultrasensitive ( less 50 copies/ml ) measure 24 week start therapy APV plus ABC plus 3TC .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Amprenavir</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive . Are least 18 year old . Have little antiHIV drug experience ( see detail ) never take ABC . Have CD4 count great equal 200 cells/mm3 within 30 day prior study entry . Have viral load ( level HIV blood ) great 500 copies/ml within 30 day prior study entry . Agree use effective method birth control study . Exclusion Criteria Patients eligible study : Have take 3TC stavudine ( d4T ) . Have take protease inhibitor ( PI ) nonnucleoside reverse transcriptase inhibitor ( NNRTI ) 7 day . Have take PI within 60 day study entry . Have history diabetes . Have history untreated gonad thyroid disorder . Have stomach intestinal disorder may affect way body absorb study drug , may make unable take medication mouth . Have receive chemotherapy radiation within 4 week prior entry , need either study period . Have lose gain significant amount weight ( great 5 % ) within past 2 month . Have serious medical condition , heart disease . Are allergic study drug . Have treat infection medical illness within 14 day prior study entry . Have fever ( 38.5 degree Celsius ) 7 day chronic diarrhea ( 3 liquid stool per day 15 day ) within 30 day prior study entry . Have AIDSrelated cancer ( Kaposi 's sarcoma ) . Abuse alcohol drug . Have receive certain medication . Are pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2000</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>Carbohydrates</keyword>
	<keyword>VX 478</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Lipids</keyword>
	<keyword>Insulin Resistance</keyword>
	<keyword>abacavir</keyword>
</DOC>